Myosana Therapeutics
- Justin Fallon
Justin has decades of neuromuscular disease research & developed Biglycan as a potential therapy for DMD. He is currently the Scientific Founder and SAB Chairman of Bolden Therapeutics.
Org chart
This person is not in the org chart
Teams
This person is not in any teams
